A scientific approach
Fluid has been working with Opthea for a number of years on their annual report, with two primary goals. The first is to report on the past year’s financial performance. The second is to showcase the advances in science that Opthea has made into identifying the cause of Age-Related Macular Degeneration (AMD) and Diabetic Macular Oedema (OME). Significant advances in medical treatment creates the opportunity to tell a compelling narrative via the annual report, with the purpose of educating and growing awareness of wet age-related macular degeneration, which affects more than one million Australians over the age of fifty.
Championing a better future
Opthea is dedicated to helping patients with inadequately treated wet AMD. The annual report focuses on building an engaging narrative that visually brings to life some of the common issues, with faces of patients who suffer from AMD. For patients who suffer the degenerative eye disease, focus is often affected and the centre of the visual field required for detailed, sharp vision, such as reading, recognising faces, and driving a car is significantly blurred.